258 related articles for article (PubMed ID: 26043812)
21. Collection, storage, inspection and quality control of platelet concentrates obtained by apheresis: The situation in Spain.
Castrillo A; Jimenez-Marco T; Arroyo JL; Jurado ML; Larrea L; Maymo RM; Monge J; Muñoz C; Pajares Á; Yáñez M;
Transfus Apher Sci; 2017 Jun; 56(3):357-361. PubMed ID: 28319015
[TBL] [Abstract][Full Text] [Related]
22. Seven-day storage of apheresis platelets: report of an in vitro study.
Dumont LJ; VandenBroeke T
Transfusion; 2003 Feb; 43(2):143-50. PubMed ID: 12559008
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of platelets componentized with the Reveos Automated Blood Processing System and stored for 7 days at room temperature in a non-Di(2-ethylhexyl) phthalate (DEHP) platelet pooling set.
Reddoch-Cardenas KM; Perez SL; Ferdin JN; Meledeo MA
Transfusion; 2024 May; 64 Suppl 2():S146-S154. PubMed ID: 38491915
[TBL] [Abstract][Full Text] [Related]
24. Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient.
Tynngård N; Boknäs N; Trinks M; Dreimane A; Berlin G
Transfusion; 2019 Feb; 59(2):723-728. PubMed ID: 30548486
[TBL] [Abstract][Full Text] [Related]
25. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologies.
Millar D; Hayes C; Jones J; Klapper E; Kniep JN; Luu HS; Noland DK; Petitti L; Poisson JL; Spaepen E; Ye Z; Maurer-Spurej E
Transfusion; 2020 Sep; 60(9):2067-2078. PubMed ID: 32729161
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.
Johnson L; Winter KM; Hartkopf-Theis T; Reid S; Kwok M; Marks DC
Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041
[TBL] [Abstract][Full Text] [Related]
28. [Activation of random-donor platelet concentrates and platelet prepared from random-donor apheresis collections during storage].
Lin JJ; Fan HH; Ma Q; Feng ML; Shen XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):458-61. PubMed ID: 12513749
[TBL] [Abstract][Full Text] [Related]
29. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
Seghatchian J
Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
[TBL] [Abstract][Full Text] [Related]
30. In vitro quality of apheresis platelets divided into paediatric-sized units and stored in PVC bags plasticised with TOTM, BTHC or DINCH.
Bashir S; Meli A; Cardigan R
Transfus Med; 2018 Oct; 28(5):380-385. PubMed ID: 29644730
[TBL] [Abstract][Full Text] [Related]
31. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
32. Phosphatidylserine exposure in platelet concentrates during the storage period: differences between the platelets collected with different cell separators.
Lai M; Rumi C; D'Onofrio G; Puggioni PL; Menichella G; Candido A; Leone G
Transfus Apher Sci; 2002 Dec; 27(3):239-45. PubMed ID: 12509219
[TBL] [Abstract][Full Text] [Related]
33. P38 mitogen activated protein kinase inhibitor improves platelet in vitro parameters and in vivo survival in a SCID mouse model of transfusion for platelets stored at cold or temperature cycled conditions for 14 days.
Skripchenko A; Gelderman MP; Vostal JG
PLoS One; 2021; 16(5):e0250120. PubMed ID: 33974660
[TBL] [Abstract][Full Text] [Related]
34. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
35. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
Zeiler T; Gritzka D; Karger R; Kretschmer V
Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
[TBL] [Abstract][Full Text] [Related]
36. Binding of activated platelets to WBCs in vivo after transfusion.
Gutensohn K; Geidel K; Brockmann M; Siemensen M; Krueger W; Kroeger N; Kuehnl P
Transfusion; 2002 Oct; 42(10):1373-80. PubMed ID: 12423523
[TBL] [Abstract][Full Text] [Related]
37. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
38. In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days.
Braathen H; Sivertsen J; Lunde THF; Kristoffersen EK; Assmus J; Hervig TA; Strandenes G; Apelseth TO
Transfusion; 2019 Aug; 59(8):2652-2661. PubMed ID: 31150571
[TBL] [Abstract][Full Text] [Related]
39. Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS+ apheresis platelets.
Mastroianni MA; Llohn AH; Akkök ÇA; Skogheim R; Ødegaard ER; Nybruket MJ; Flesland A; Mousavi SA
Transfus Apher Sci; 2013 Oct; 49(2):285-90. PubMed ID: 23820429
[TBL] [Abstract][Full Text] [Related]
40. Preparation, storage and quality control of platelet concentrates.
Tynngård N
Transfus Apher Sci; 2009 Oct; 41(2):97-104. PubMed ID: 19699153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
